Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of Genetic Variants on Steady-State Etonogestrel Concentrations Among Contraceptive Implant Users

26 Mar 2019

Abstract excerpt

OBJECTIVE: To identify genetic variants that influence steady-state etonogestrel concentrations among contraceptive implant users. METHODS: We enrolled healthy, reproductive-age women in our pharmacogenomic study using etonogestrel implants for 12-36 months without concomitant use of hepatic enzyme inducers or inhibitors. We collected participant characteristics, measured serum etonogestrel concentrations, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Pregnancy and Medication Impact
Share to Reproductive Health and Contraception
Share to Reproductive System and Pregnancy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30870275
DOI: 10.1097/aog.0000000000003189

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of Genetic Variants on Steady-State Etonogestrel Concentrations Among Contraceptive Implant UsersPMID 30870275Read ↗

Effect of patient genetics on etonogestrel pharmacokinetics when combined with efavirenz or nevirapine ARTSemantic proximity Read ↗

Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.Semantic proximity Read ↗

Estrogen receptor genotypes, menopausal status, and the effects of tamoxifen on lipid levels: revised and updated results.Semantic proximity Read ↗

Epigenome-wide DNA methylation signatures associated with combined hormonal contraceptive useSemantic proximity Read ↗

Integrating Pharmacokinetic, Pharmacogenomic, and Clinical Risk Data to Individualise Hormonal Contraception and Minimise Thrombotic Risk: A Translational Framework.Semantic proximity Read ↗

Polymorphisms associated with circulating sex hormone levels in postmenopausal women.Semantic proximity Read ↗

Whole-exome sequencing reveals novel candidate single nucleotide variations for preventing adverse effects of levonorgestrel implantation.Semantic proximity Read ↗

Pharmacodynamic Interaction Analysis of Dydrogesterone, Progesterone, and Estradiol in Combination-Progestin HRT Frozen Embryo Transfer: a prospective clinical cohort studySemantic proximity Read ↗

SLCO1B1 genetic variation and hormone therapy in menopausal women.Semantic proximity Read ↗

Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women.Semantic proximity Read ↗

Invited review: Pharmacogenetics of estrogen replacement therapy.Semantic proximity Read ↗

Effect of hormone metabolism genotypes on steroid hormone levels and menopausal symptoms in a prospective population-based cohort of women experiencing the menopausal transition.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.